Baird Financial Group Inc. Boosts Stock Holdings in Lam Research Corporation $LRCX

Baird Financial Group Inc. boosted its stake in Lam Research Corporation (NASDAQ:LRCX) by 28.6% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 667,781 shares of the semiconductor company’s stock after purchasing an additional 148,431 shares during the quarter. Baird Financial Group Inc. owned about 0.05% of Lam Research worth $65,002,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in LRCX. Norges Bank bought a new stake in shares of Lam Research in the second quarter worth about $1,894,585,000. Nuveen LLC purchased a new position in Lam Research during the 1st quarter valued at approximately $604,344,000. JPMorgan Chase & Co. grew its holdings in Lam Research by 14.4% during the 2nd quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock valued at $3,954,188,000 after buying an additional 5,102,589 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Lam Research by 99.7% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company’s stock worth $417,242,000 after acquiring an additional 2,864,863 shares in the last quarter. Finally, Nordea Investment Management AB boosted its position in shares of Lam Research by 34.1% during the 2nd quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company’s stock valued at $1,029,210,000 after acquiring an additional 2,692,189 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.

Insider Activity at Lam Research

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. This represents a 17.21% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the transaction, the director directly owned 1,652 shares in the company, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 102,608 shares of company stock valued at $14,916,496 in the last quarter. Corporate insiders own 0.31% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Wall Street Zen cut shares of Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. BNP Paribas Exane lifted their price objective on shares of Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. Wells Fargo & Company upped their target price on shares of Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a research report on Thursday, October 23rd. TD Cowen increased their price target on shares of Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Twenty-six investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $152.87.

Lam Research Price Performance

Shares of LRCX stock opened at $157.09 on Friday. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $167.15. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The firm has a market capitalization of $197.31 billion, a P/E ratio of 34.60, a P/E/G ratio of 1.64 and a beta of 1.77. The stock has a 50 day moving average price of $149.41 and a 200 day moving average price of $116.60.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the prior year, the company posted $0.86 EPS. Lam Research’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, sell-side analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be issued a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. Lam Research’s dividend payout ratio (DPR) is presently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.